Cholesterol concentrations and clinical response to sertraline in patients with epilepsy: Preliminary results

Epilepsy and Behavior

Volumn 19, Issue 3, 2010, Pages 509-512

  Machado, René Andrade ^a   Espinosa, Arlety García ^b   Montoto, Ariadna Perez ^a  

^a Epilepsy Section   (Cuba)

^b Psychiatry Hospital Eduardo Bernabé Ordaz   (Cuba)

Author keywords

Cholesterol value; Depression; Open label trial; Suicidality; Temporal lobe epilepsy

Indexed keywords

CHOLESTEROL; CLOBAZAM; GABAPENTIN; LAMOTRIGINE; SERTRALINE; VALPROIC ACID;

ADULT; ARTICLE; BIPOLAR DISORDER; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MALE; MONOTHERAPY; OPEN STUDY; POLYPHARMACY; PREDICTOR VARIABLE; PROSPECTIVE STUDY; PSYCHIATRIST; STRUCTURED INTERVIEW; SUICIDE ATTEMPT; TEMPORAL LOBE EPILEPSY; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; CHOLESTEROL; DEPRESSIVE DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; EPILEPSY, TEMPORAL LOBE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; SUICIDE, ATTEMPTED;

EID: 78649904014     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2010.06.045     Document Type: Article

References (11)

1. Scorza F.A., Terra V.C., Arida R.M., Albuquerque M. How low can we go? A possible relationship between low plasma cholesterol levels and suicide in people with epilepsy. Epilepsy Behav 2009, 16:368.
2. Garcia-Espinosa A., Andrade-Machado R., Borges-González S., García-González M.E., Pérez-Montoto A., Toledo-Sotomayor G. Wisconsin Card Sorting Test performance and impulsivity in patients with temporal lobe epilepsy: suicidal risk and suicide attempts. Epilepsy Behav 2010, 17:39-45.
3. Boscarino J.A., Erlich P.M., Hoffman S.N. Low serum cholesterol and external cause mortality: potential implications for research and surveillance. J Psychiatr Res 2009, 43:848-854.
4. Sheehan D.V., Lecrubier Y., Sheehan K.H., et al. The Mini International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998, 59(Suppl. 20):22-33.
5. Hamilton M. Development of a rating scale for primary depressive illness. Br J Social Clin Psychol 1967, 6:278-296.
6. Plutchik R., van Praag H.M. The measurement of suicidality, aggressivity and impulsivity. Prog Neuropsychopharmacol Biol Psychiatry 1989, 13:23-24. (Suppl.).
7. Troisia A., Molesb A., Panepucciac L., Lo Russoc L., Pallac G., Scucchid S. Serum cholesterol levels and mood symptoms in the postpartum period. Psychiatry Res 2002, 109:213-219.
8. Jean-Claude Alvarez J.C., Cremniter D., Gluck N., et al. Low serum cholesterol in violent but not in non-violent suicide attempters. Psychiatry Res 2000, 95:103-108.
9. Kanner A.M. Depression and epilepsy: a review of multiple facets of their close relation. Neurol Clin 2009, 27:865-880.
10. Favale E., Audenino D., Cocito L., et al. The anticonvulsant effect of citalopram as an indirect evidence of serotonergic impairment in human epileptogenesis. Seizure 2003, 12:316-318.
11. Scott M. Metabolic consequences of antiepileptic drugs. Curr Opin Neurol 2010, 23:164-169.